Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
2 Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010
Steve Street, Doug Phillips
Mark Turrell, Tim Woods
Anne Rogers, Kurt Detloff
Jon Bidwell
Howard Smith
Mike Hatrick, Dave Wootten
Employer
Partner
colleagues sharing data
Many Thanks
Outline
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 3
• Why do things differently?
• The Challenge Model
• The Long Tail in Collaborative Innovation
• Risk-Management Tactics
Bonafides and Context
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 4 4
• World’s largest pharmaceutical company
• $7 billion annual R&D
• Tightly focused, managed research teams
• Scientist & manager, 29 years in R&D
• Past 5 years leading innovation initiative
• Retired, 2nd career developing collaborative intelligence systems
me
Outline
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 5
Why do things differently?
You must master things...
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 6
In Science Business, Gary Pisano notes that biopharma survival depends on mastery of the
• complexity
• uncertainty
• speed of change
of the underlying science.
Gary Pisano (2006) Science Business
...that you don’t know inside your company
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 7 7
Pfizer spent more on research in 2007 than any other company in the world.
JAMA, September 21, 2005—Vol 294, No. 11 1333 http://www.nsf.gov/statistics/seind00/access/c2/c2h.htm
Pfizer medical device firms
foundations & charities
rest of world
other government
biotechnology firms
other pharmaceutical
firms
National Institutes of
Health
USA But that represents only
1.7% of the world’s biomedical R+D spending,
1.4% of the world’s biomedical scientists
Outline
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 8
The Challenge Model
9 Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010
The “Idea Farm” is an all-company collaborative innovation and problem-solving system.
We ran 30-50 campaigns every year.
This approach is known to be effective and sustainable.
Scaling up open collaboration inside is a perfect prelude to Open Innovation.
Pfizer experience
10 Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010
? ?
Diverge-Converge
The diverge-converge model is centuries old, proven effective, and scales perfectly with electronic media.
The classic example is the Longitude Act of 1714; see Dava Sobel’s book Longitude
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 11
Case Studies by Scale and Type
social problem-solving
meeting and decision support
Continuous Improvement
outside supplier & partner challenges
portfolios & priorities : Speed Dates
portfolios & priorities : large challenges
difficult scientific challenges
interactive communications
Outline
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 12
The Long Tail
The Long Tail
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 13
There is a Long Tail of large scale collaboration behavior.
Chris Anderson’s book tells the story for retail books and music. His observations, conclusions, and advice apply directly to collaborative innovation.
It matters because the results are non-obvious, universal, and now predictable.
Classic vs Long Tail Statistics
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 14
What’s the average height of people?
What’s the average number of ideas from
our employees?
ideas per person
how
ofte
n it
occu
rs
• It’s nothing like a bell curve.
• “Average” makes no sense.
• Some people enter no ideas, some enter hundreds. The range is huge.
inches of height per person
how
ofte
n it
occu
rs
• It’s a bell curve.
• “Average” is a useful description.
• The range of values is only a factor of 2.
Log-log graphs reveal the tail
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 15
linear graph
Log-log plots show the tail clearly.
A straight line on a log-log graph has the form y = Cx-b , a power law.
I graph these like Zipf, with the axes are flipped vs the Pareto convention. Slopes here = b = 1/(α-1)
log-log
Pfizer Idea Farm 2006-2009 20,000 entries from 4000 authors in >200 campaigns
Long Tails are everywhere
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 16
• book and music sales
• word usage
• internet hits
• salaries
• avalanches
• wildfires
M. E. J. Newman (2006) Power laws, Pareto distributions and Zipf’s law, http://arxiv.org/abs/cond-mat/0412004v3
Many Companies, One Phenomenon
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 17
Each dataset is a single campaign at a different company.
Lines all have α=3.0
18 Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010
These are huge datasets over 3-4 years and thousands of people each.
These very different businesses show identical behavior patterns.
Cargill and Pfizer
Voluntary External Contributions
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 19
An external open-transom system has exactly the same pattern of contributions.
Data from several years of Pfizer’s open contribution system, courtesy of Doug Phillips
Long Tails in Public Forums
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 20
M. E. J. Newman, Power laws, Pareto distributions and Zipf’s law, 2004
D. Wilkinson, Strong regularities in online peer production, in Proceedings of the 2008 ACM Conference on E-Commerce, Chicago, IL, July 2008
Long tails (power laws) are the norm for large scale voluntary contributions.
Wikipedia and Digg
The Value of a Contribution
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 21
The value* of an entry from a top contributor is the same as that from a rare contributor.
The huge number of singleton authors puts their value far ahead of the top contributors.
* Value was measured for multiple large internal challenges, assigned by rankings of the sponsoring business unit.
Lesson #1
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 22
Voluntary external behavior is different from structured internal behavior.
Internal systems are typically push, external are pull: this is a huge mindset change for motivation and management.
John Seely Brown & John Hagel III, Push Pull -- The Next Frontier of Innovation
Lesson #2
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 23
Most of your contributions and value come from the occasional contributors.
from authors of 1 idea
of 2 ideas
of 3
Internal contribution statistics are gaussian, external are power law.
Do not bias your system by quantity; you may exclude your best contributors.
Use a structured, scalable approach to evaluating the input.
Dirty Secrets of 5 Star Voting
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 24
• it’s biased
• it’s compressed
• followers drive to extremes
• don’t make it too easy
How public opinion forms, Fang Wu and Bernardo A. Huberman, Social Computing Lab, HP Labs, Palo Alto, CA 94304, http://www.hpl.hp.com/research/scl/papers/howopinions/wine.pdf
Is the crowd’s wisdom biased? A quantitative assessment of three online communities, Vassilis Kostakos, at http://arxiv.org/pdf/0909.0237
“...when people observe previous opinions ... they tend to follow the trend. As a result ... extreme views get reinforced and become increasingly more extreme.
“... where expressing a view is costly, like when writing a book review...people will tend to ... offset the current view by presenting a differing one.”
“This analysis has shown that the wisdom of the crowd is indeed biased.”
Analysis of Amazon: 380,000 reviews of 21,000 books by 134,000 people
Amazon average is 4.4 out of 5
Lesson #3
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 25 sources: Twitter: Heil and Piskorski, Harvard Business School October 2009; Digg, Wikipedia: Wilkinson, Hewlett-Packard labs; other, this work
What percent of people put in 80% of the content? 80%
Twitter tweets 5%
Digg votes
9%
comments, star votes
21- 28%
Wikipedia edits
46%
corporate ideas
58- 68%
info
rmat
ion
cont
ent
The simpler the task, the less representative the results. Be very suspicious of mass ratings.
Outline
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 26
Risk Management Tactics in Open
Innovation
Ask Valuable but Low-Risk Questions
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 27
• Which of our policies and procedures makes your CRO task onerous?
• What are the bottlenecks in regulatory document preparation?
• Can you make this molecule for under $200/kilo?
• We have a new drug for diabetes in Phase III. What could you do with it in other disease areas?
Ask for help in finding problems, not solutions.
Start with optimization, not new opportunities.
Offer an opportunity you wouldn’t exploit anyway.
examples
Ask Different Questions
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 28
inside supply chain & partners Open Innovation
Approach Open Innovation in Stages
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 29 29
A staged approach prepares for, and minimizes, IP risk when going outside
project team
whole company
partners, suppliers rest of world
know
ledg
e
time
risk
Good Reading
Rob Spencer, CHI Collaborative Innovation in Biomedicine, Philadelphia, June 2010 30
• John Seely Brown & John Hagel III, Push Pull -- The Next Frontier of Innovation, McKinsey Quarterly 2005 no 3, 82-91.
• John Hagel & John Seely Brown, From Push to Pull - Emerging Models for Mobilizing Resources, working paper, Oct 2005.
• Gary Pisano, Science Business, 2006, HBR Press
• Gary Hamel, The Future of Management, 2007
• Thomas Friedman, The World is Flat, 2006
• Managing Uncertainty, Harvard Business Review
• Strategy Under Uncertainty, HBR OnPoint reprint
• Peter Senge, The Fifth Discipline
Contact information
Robin W. Spencer [email protected] 860-326-8077